| Q53270487 | A bioelectronic system for insulin release triggered by ketone body mimicking diabetic ketoacidosis in vitro. |
| Q90682790 | A forskolin-conjugated insulin analog targeting endogenous glucose-transporter for glucose-responsive insulin delivery |
| Q41144817 | ATP-Responsive Drug Delivery Systems |
| Q39016466 | ATP-triggered anticancer drug delivery |
| Q37581374 | Accelerating the Translation of Nanomaterials in Biomedicine |
| Q44877496 | Advances in bioresponsive closed-loop drug delivery systems |
| Q47603282 | Advances in pH-Sensitive Polymers for Smart Insulin Delivery |
| Q41809051 | Affinity-controlled protein encapsulation into sub-30 nm telodendrimer nanocarriers by multivalent and synergistic interactions |
| Q48266863 | Analyte-Responsive Hydrogels: Intelligent Materials for Biosensing and Drug Delivery. |
| Q41974259 | Bio-inspired synthetic nanovesicles for glucose-responsive release of insulin |
| Q49994683 | Biomedical nanomotors: efficient glucose-mediated insulin release |
| Q52373088 | Bioresponsive Microneedles with a Sheath Structure for H2 O2 and pH Cascade-Triggered Insulin Delivery. |
| Q57428689 | Bioresponsive materials |
| Q91910650 | Charge-switchable polymeric complex for glucose-responsive insulin delivery in mice and pigs |
| Q58557680 | Chitosan-Based Nanomaterials for Drug Delivery |
| Q49889663 | Core-Shell Microneedle Gel for Self-Regulated Insulin Delivery. |
| Q49788020 | Determination of glycated albumin using boronic acid-derived agarose beads on paper-based devices |
| Q57368584 | Doubly responsive polymersomes towards monosaccharides and temperature under physiologically relevant conditions |
| Q98771601 | Drug Delivery System in the Treatment of Diabetes Mellitus |
| Q37283351 | Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies. |
| Q96302603 | Electrochemical Immunoassay for Determination of Glycated Albumin using Nanozymes |
| Q38226941 | Emerging chitin and chitosan nanofibrous materials for biomedical applications. |
| Q38195730 | Emerging micro- and nanotechnology based synthetic approaches for insulin delivery |
| Q43090904 | Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus |
| Q57436349 | Engineering Synthetic Insulin-Secreting Cells Using Hyaluronic Acid Microgels Integrated with Glucose-Responsive Nanoparticles |
| Q37207691 | Engineering Synthetically Modified Insulin for Glucose-Responsive Diabetes Therapy. |
| Q26992127 | Enzyme-responsive nanomaterials for controlled drug delivery |
| Q92089638 | Glucose transporter inhibitor-conjugated insulin mitigates hypoglycemia |
| Q44870456 | Glucose-Responsive Insulin Delivery by Microneedle-Array Patches Loaded with Hypoxia-Sensitive Vesicles |
| Q88921796 | Glucose-Responsive Microneedle Patches for Diabetes Treatment |
| Q38903101 | Glucose-Triggered Insulin Release from Fe3+ -Cross-linked Alginate Hydrogel: Experimental Study and Theoretical Modeling. |
| Q44875590 | Glucose-responsive insulin by molecular and physical design |
| Q89518612 | Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs |
| Q39118683 | Glucose-responsive insulin release: Analysis of mechanisms, formulations, and evaluation criteria |
| Q57366973 | Glucose-responsive microgels based on apo-enzyme recognition |
| Q92497645 | High drug-loading gold nanoclusters for responsive glucose control in type 1 diabetes |
| Q33592673 | Human islet xenotransplantation in rodents: A literature review of experimental model trends |
| Q34568748 | Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria |
| Q28468535 | Injectable and Glucose-Responsive Hydrogels Based on Boronic Acid-Glucose Complexation |
| Q38996671 | Injectable biomaterials for stem cell delivery and tissue regeneration |
| Q50910910 | Insulin-coated gold nanoparticles as a new concept for personalized and adjustable glucose regulation. |
| Q47262860 | Intestinal organoids containing poly(lactic-co-glycolic acid) nanoparticles for the treatment of inflammatory bowel diseases |
| Q37206887 | Light-Activated Hypoxia-Responsive Nanocarriers for Enhanced Anticancer Therapy. |
| Q44875445 | Locally Induced Adipose Tissue Browning by Microneedle Patch for Obesity Treatment. |
| Q46273846 | Long-term Effect of Biomineralized Insulin Nanoparticles on Type 2 Diabetes Treatment |
| Q36574654 | Managing diabetes with nanomedicine: challenges and opportunities |
| Q47643311 | Mediatorless, Reversible Optical Nanosensor Enabled through Enzymatic Pocket Doping. |
| Q47108056 | Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy. |
| Q34481917 | Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery |
| Q37206883 | Microneedles Integrated with Pancreatic Cells and Synthetic Glucose-Signal Amplifiers for Smart Insulin Delivery |
| Q53636879 | NIR upconversion fluorescence glucose sensing and glucose-responsive insulin release of carbon dot-immobilized hybrid microgels at physiological pH. |
| Q38232948 | Nanogel--an advanced drug delivery tool: Current and future |
| Q36936204 | Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug Delivery |
| Q38605185 | Nanotechnology for protein delivery: Overview and perspectives |
| Q38651285 | Nanotechnology: History and future |
| Q50541300 | Part-2: Analytical Expressions of Concentrations of Glucose, Oxygen, and Gluconic Acid in a Composite Membrane for Closed-Loop Insulin Delivery for the Non-steady State Conditions. |
| Q92826127 | Polymer-Based Nanoparticle Strategies for Insulin Delivery |
| Q50169459 | Polymeric microneedles for transdermal protein delivery |
| Q54958449 | Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside. |
| Q57498734 | Preparation of particulate polymeric therapeutics for medical applications |
| Q98184106 | Protein-responsive protein release of supramolecular/polymer hydrogel composite integrating enzyme activation systems |
| Q47753615 | Rational Design of Glucose-Responsive Insulin Using Pharmacokinetic Modeling |
| Q27010516 | Recent advances in nanotechnology for diabetes treatment |
| Q44870674 | Red Blood Cells for Glucose-Responsive Insulin Delivery |
| Q44869913 | Relay Drug Delivery for Amplifying Targeting Signal and Enhancing Anticancer Efficacy |
| Q30548038 | Robust self-healing hydrogels assisted by cross-linked nanofiber networks |
| Q59808657 | Role of Endocrine-Disrupting Engineered Nanomaterials in the Pathogenesis of Type 2 Diabetes Mellitus |
| Q46210517 | Self-Assembled Colloidal Gel Using Cell Membrane-Coated Nanosponges as Building Blocks. |
| Q40469273 | Self-folded redox/acid dual-responsive nanocarriers for anticancer drug delivery. |
| Q33742934 | Smart approaches to glucose-responsive drug delivery |
| Q47331571 | Smart conjugated polymer nanocarrier for healthy weight loss by negative feedback regulation of lipase activity |
| Q26776370 | Smart nanosystems: Bio-inspired technologies that interact with the host environment |
| Q30368021 | Spatiotemporal drug delivery using laser-generated-focused ultrasound system. |
| Q50904654 | Stimuli-Responsive Delivery of Therapeutics for Diabetes Treatment. |
| Q35088244 | Stimuli-responsive nanomaterials for therapeutic protein delivery |
| Q48279444 | Structural arrest and dynamic localization in biocolloidal gels |
| Q57368664 | Switchable glucose-responsive volume phase transition behavior of poly(phenylboronic acid) microgels |
| Q35050853 | Synthesis of mesoporous silica-gel core-shell structural microparticles and their multiple drug delivery |
| Q35726984 | Tattoo ink nanoparticles in skin tissue and fibroblasts |
| Q26744837 | The Smart Drug Delivery System and Its Clinical Potential |
| Q89592279 | Triggered Release of Loads from Microcapsule-in-Microcapsule Hydrogel Microcarriers: En-Route to an "Artificial Pancreas" |
| Q57426775 | Ultrasound-triggered noninvasive regulation of blood glucose levels using microgels integrated with insulin nanocapsules |
| Q30410088 | Ultrasound-triggered regulation of blood glucose levels using injectable nano-network. |
| Q39351089 | Updates on smart polymeric carrier systems for protein delivery. |
| Q50620432 | pH-Responsive and near-infrared-emissive polymer nanoparticles for simultaneous delivery, release, and fluorescence tracking of doxorubicin in vivo. |